Birdwatch Note Rating
2025-01-11 04:39:49 UTC - HELPFUL
Rated by Participant: C012ED0CB2EEAB00E1473B0C602FE999667961E32FB418EBE1424EF81EFBA54D
Participant Details
Original Note:
The WHO reported disproportionately high number of reports of liver and kidney problems in patients receiving remdesivir compared with patients receiving other drugs for COVID-19. https://www.science.org/content/article/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug European Medicines Agency has opened a safety committee on the issue: https://www.ema.europa.eu/en/medicines/human/EPAR/veklury
All Note Details